Trials / Sponsors / Beijing Dongfang Biotech Co., Ltd.
Beijing Dongfang Biotech Co., Ltd.
Industry · 6 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Active Not Recruiting | A Phase 3 Study to Evaluate the Efficacy of JY09 Compared With Dulaglutide in Combination Therapy Diabetes Mel Type2 Diabetes Mellitus | Phase 3 | 2024-07-17 |
| Active Not Recruiting | A Phase 3 Study to Evaluate the Efficacy of JY09 Compared With Placebo in T2DM Patients Type 2 Diabetes Mellitus | Phase 3 | 2024-07-10 |
| Completed | Influence of JY09 on Pharmacokinetics of Metformin , Rosuvastatin , and Digoxin and the QT Interval Study in O Diabetes Mellitus, Type 2, Overweight | Phase 1 | 2023-10-19 |
| Unknown | JY025 is a First-line Treatment for EGFR Mutated NSCLC Phase II and III Clinical Trials of Efficacy and Safety NSCLC | Phase 2 / Phase 3 | 2021-07-30 |
| Completed | Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of JY09 Diabetes Mellitus, Type 2 | Phase 1 | 2018-04-26 |
| Unknown | a Study of JY09 in Chinese Healthy Subjects Healthy | Phase 1 | 2016-12-01 |